Table 2 Safety profile of acarbose, 5-year surveillance study (n = 1,954) [34].
Side-effect | n | Proportion of total population (%) |
|---|---|---|
Gastrointestinal | 76 | 3.9 |
Flatulence | 68 | 3.5 |
Diarrhoea | 13 | 0.7 |
Loose stool | 1 | <0.1 |
Abdominal | 4 | 0.2 |
Nausea | 3 | 0.2 |
Constipation | 1 | <0.1 |
Metabolic | 10 | 0.5 |
Body as a whole | 5 | 0.3 |